Reference is made to the stock exchange announcement dated
13 February 2014concerning the subsequent offering of 3,500,000 shares in Serodus ASA("Serodus" or the "Company") at a subscription price of NOK 3.00per share. The following primary insiders of the Company have been allocated shares in connection with the subsequent offering: Eva Steiness, CEO of Serodus, has been allocated 35,301 Offer Shares through her ownership in Newpharma. Following this allocation, Newpharma will own 796,141 shares in Serodus.
Torben Skarsfeldt, senior project manager in
Trygve Gulbrandsen, CSO in Serodus, has been allocated 10,170 Offer Shares. Following this allocation, Trygve Gulbrandsenwill own 37,308 shares in Serodus.
Click here for more information: http://www.newsweb.no/index.jsp?messageId=345800